Health Technology Assessment

Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation

  • Type:
    Extended Research Article
  • Authors:
    Main C, Bojke L, Griffin S, Norman G, Barbieri M, et al.
  • Journal:
    Health Technology Assessment
  • Issue:
    Volume: 10, Issue: 9
  • Published:
  • Citation:
    Main C, Bojke L, Griffin S, Norman G, Barbieri M, et al. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation. Health Technol Assess 2006;10(9). https://doi.org/10.3310/hta10090
  • DOI:
    https://doi.org/10.3310/hta10090
Crossmark status check

Toolkit

View Award

The full text of this issue is available as a PDF document from the Toolkit section on this page

We are currently working on improvements to this feature. Please check back soon for updates